Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
Plos One|January 30, 2020
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register studyFrederik B Thomsen, Marcus Westerberg, Hans Garmo, et al.
European Urology|March 6, 2012
Concordance of tumor differentiation among brothers with prostate cancerK Fredrik Jansson, Olof Akre, Hans Garmo, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of SwedenGiuseppe Fallara, Charlotte Alverbratt, Hans Garmo, et al.
Psycho-Oncology|August 12, 2020
Changes in lifestyle among prostate cancer survivors: A nationwide population-based studyOskar Bergengren, Anna Pia Enblad, Hans Garmo, et al.
International Journal of Cancer|October 10, 2019
No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritisNils P Hailer, Anne Garland, Max Gordon, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2024
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PCAstrid E Persson, Elisabeth Kjellén, Hans Garmo, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Plos One|January 30, 2020
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register studyFrederik B Thomsen, Marcus Westerberg, Hans Garmo, et al.
European Urology|March 6, 2012
Concordance of tumor differentiation among brothers with prostate cancerK Fredrik Jansson, Olof Akre, Hans Garmo, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2021
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of SwedenGiuseppe Fallara, Charlotte Alverbratt, Hans Garmo, et al.
Psycho-Oncology|August 12, 2020
Changes in lifestyle among prostate cancer survivors: A nationwide population-based studyOskar Bergengren, Anna Pia Enblad, Hans Garmo, et al.
International Journal of Cancer|October 10, 2019
No generally increased risk of cancer after total hip arthroplasty performed due to osteoarthritisNils P Hailer, Anne Garland, Max Gordon, et al.
BJU International|April 19, 2017
Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancerDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2024
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 13, 2025
Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PCAstrid E Persson, Elisabeth Kjellén, Hans Garmo, et al.
International Journal of Cancer|March 10, 2011
Ischemic heart disease and stroke before and during endocrine treatment for prostate cancer in PCBaSe SwedenDavid Robinson, Hans Garmo, Bertil Lindahl, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 8, 2011
Association between levels of C-reactive protein and leukocytes and cancer: three repeated measurements in the Swedish AMORIS studyMieke Van Hemelrijck, Lars Holmberg, Hans Garmo, et al.
Pageof 27